5 surprising predictions in the medical field for 2024

They explain, “SARS-CoV-2 has changed continuously during the pandemic, resulting in the emergence of variants that differ from the original SARS-CoV-2 virus.”

Now there may be concerns about vaccines against these variants.

“My concern is that if variants evolve in a different direction and existing vaccines become obsolete, we will have to design new vaccinesOr the essential antivirals we currently use will become obsolete and we will have to design a new one,” Al-Aly said.

So, given this scenario, another prediction about COVID for 2024 is that new vaccines may arrive.

AI against lung cancer

Lung cancer is one of the deadliest cancers, In part, this is because this type of cancer is often diagnosed late, so earlier diagnosis may allow for better, more effective treatment against this disease.

In fact, 2024 could be a year in which we see Advances in early diagnosis of lung cancer, And a group of researchers in the United Kingdom are testing an artificial intelligence (AI) system to diagnose this type of cancer from chest X-rays.

The trial will involve 150,000 patients across six UK hospitals and is one of According to the prestigious journal Nature Medicine, 11 clinical trials that will shape medicine in 2024.

“We will complete recruitment in July 2024 and results are expected in 2024. Our hypothesis based on our previous research is that we can identify lung cancer earlier and Reduce diagnosis time by up to 50%“, the researchers told Nature Medicine.

antiobesity drugs

There has certainly been a revolution in anti-obesity drugs by 2023, even drugs that were not originally designed to control body weight but that many people are using for that purpose. There are, and now they too are in short supply. For example, this is the case with Ozempic.

In 2024, treatment against overweight and obesity will remain at the center In the field of medicine, noting the promotion of GLP-1-based drugs, which have demonstrated significant results and have been named ‘Breakthrough of the Year’ by Science magazine.

There are great expectations regarding these types of medicines from 2024 and the coming years. He GLP-1 An article from Elsevier states, “It is an incretin-like hormone that contributes to the control of glucose homeostasis.”

But, Plays a regulatory role in food intakeInduces a feeling of satiety, and has beneficial effects in central and peripheral neurodegenerative syndromes.

“In any case, the importance of the potential therapeutic role of GLP-1 not only in diabetes but also in obesity and cardiovascular and nerve diseases is a fact that should not be ignored,” they highlight.

Now, about what to expect this year, “In 2024, advances in the treatment of obesity and related diseases will continue to be an important topic for the region. A consensus report from Evaluate suggests, “The enormous valuations currently held by Lilly and Novo Nordisk, the leaders in this field, are reinforced by the confidence that their medicines will drive radical improvements in the health of large segments of the population.” Will help to give.” Pharma, L. Global Review.

Treatment for ALS

patients of Amyotrophic Lateral Sclerosis (ALS) So far they have few treatment options, but that may change in 2024 or 2025. A new therapeutic option against ALS may soon be approved in Europe. it The drug increases the survival of ALS patients and slows the progression of the disease.

,We hope to be able to give a new drug to ALS patients in 2024“, Elena Molina, head of Amilix, the laboratory that developed the drug in Spain, told the ‘To Your Health’ site from the Spanish newspaper La Razon. But, how does this drug work?

“This therapy is a combination of two molecules that have been shown, in phase 2 studies, to slow disease progression on the one hand and increase survival on the other,” he explains.

And he added: “It was seen that at six months there was a 25% difference in favor, that is, in slowing down the progression and preserving functionality in those who were treated. The chances of greater survival are still not Is an increase from six months”.

ALS is a disease that affects neurons in the brain, brain stem and spinal cord that control movement.

vaccine against skin cancer

There are high expectations regarding the vaccine against skin cancer, While it is expected to be available in 2025 with accelerated approval, 2024 will be a crucial year.

And this year Moderna will conduct a larger “Phase 3” study, involving up to a thousand people. Confirm authorization of skin cancer vaccineAccording to AFP.

Skin cancer is one of the most common cancers in the world, By 2023, the American Cancer Society estimates there will be approximately 97,610 new cases of melanoma and 7,990 people will die from melanoma in the United States.

For now, the United States Food and Drug Administration (FDA) and the European Medicines Agency have placed the skin cancer vaccine under accelerated review.

But, there’s more, as Moderna has announced that it is testing an mRNA vaccine against lung cancer and studying other types of cancer.


More content from Urgente24

Banco Nación enables 12 interest-free installments: how to take advantage

2024 calendar: ‘Travel’ holidays and long weekends

Attention Monotributists: AFIP Reveals Update

Japan: Daihatsu (Toyota) reveals 30-year-old lie

Intern at TN by DNU: Strong Crossover between Studio and Chronicler

Source link

About Admin

Check Also

A course to help veterinarians design strategies for their professional development and personal well-being

The World Small Animal Veterinary Association (WSAVA) and Hills Pet Nutrition have created a certificate ... Read more

Leave a Reply

Your email address will not be published. Required fields are marked *